schizophrenia.
Conditions
Interventions
The patients divide to 2groups 1- the patients on Risperidone 4 mg t0 24 mg p.o. 2- patients on Olanzapine 10 mg t0 45mg.
Treatment - Drugs
The patients divide to 2groups 1- the patients on Risperidone 4 mg t0 24 mg p.o. 2- patients on Olanzapine 10 mg t0 45mg
Sponsors
Vice chanseller of Yasuj University of medical sciences
Eligibility
Sex/Gender
All
Age
10 Years to 65 Years
Inclusion criteria
Inclusion criteria: The patients with schizophrenia are based on history, MSE, physical exam and DSMIV criteria. PANSS done at the first day of study. Before the starts of study the patients do not have to receive any drug, no pregnant and full cooperation until end of study. The patients exclude if have no any of above condition, or the existence of any side effect.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Interview- MSE-PANSS-CGI-SAS. Timepoint: Start day of study-1 month after start- 2 months after start. Method of measurement: Interview based on DSMIV- MSE-PANSS-CGI-SAS. | — |
Secondary
| Measure | Time frame |
|---|---|
| Interview-PANSS-CGI-SAS. Timepoint: start day-1 mont dayh after start day-2 month after start. Method of measurement: interview based on DSMIV-PANSS-CGI-SAS. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNazir Hashemi Mohammad Abad
Yasuj University of Medical Sciences
Outcome results
None listed